Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-06

FDA Approved: SILVER SULFADIAZINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Silver Sulfadiazine submitted by Mylan Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silver sulfadiazine (silver sulfadiazine)

Snippet

SUPPL AP for SILVER SULFADIAZINE (SILVER SULFADIAZINE)